SCHEMBL1469285

SCHEMBL1469285

CC(C)(C)OOOC(=O)c1ccccc1OOC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.45
ALDH1A1 P00352 3/20 0.45
TSHR P16473 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ELANE P08246 2/20 0.39
SLC6A3 Q01959 2/20 0.37
KDM4E B2RXH2 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
LMNA P02545 1/20 0.37
SLC6A4 P31645 1/20 0.36
HPGD P15428 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ESR1 P03372 2/20 0.34
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
HMGB1 P09429 1/20 0.34
GGT1 P19440 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4320439 0.95 HSD17B10 (0.44) HSD17B10ALDH1A1TSHRTDP1MAPT
SCHEMBL28518702 0.92 HSD17B10 (0.49) HSD17B10ALDH1A1TSHRTDP1MAPT
SCHEMBL11424877 0.87 MAPT (0.52) HSD17B10ALDH1A1TSHRTDP1MAPT
SCHEMBL28410221 0.87 HSD17B10 (0.40) HSD17B10ALDH1A1TSHRTDP1MAPT
SCHEMBL29390328 0.86 TSHR (0.53) HSD17B10ALDH1A1TSHRTDP1ELANE
SCHEMBL629428 0.86 TSHR (0.53) HSD17B10ALDH1A1TSHRTDP1ELANE
SCHEMBL2507510 0.85 HSD17B10 (0.44) HSD17B10ALDH1A1TSHRTDP1MAPT
SCHEMBL31571285 0.81 ELANE (0.58) HSD17B10ALDH1A1TSHRTDP1MAPT
SCHEMBL29288745 0.81 HSD17B10 (0.53) HSD17B10ALDH1A1TSHRTDP1MAPT
SCHEMBL5435699 0.80 ALDH1A1 (0.51) HSD17B10ALDH1A1TSHRTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113121945-A Flexible transparent material 财团法人工业技术研究院 2021-07-16 CN disclosed
CN-110770299-A Resin composition, method for producing resin composition, and molded article 旭化成株式会社 2020-02-07 CN disclosed
US-9150670-B2 Near-infrared absorptive dye-containing curable composition, ink composition and method of producing near-infrared absorptive filter FUJIFILM CORPORATION (JP) 2015-10-06 US disclosed
US-20110070407-A1 NEAR-INFRARED ABSORPTIVE DYE-CONTAINING CURABLE COMPOSITION, INK COMPOSITION AND METHOD OF PRODUCING NEAR-INFRARED ABSORPTIVE FILTER FUJIFILM CORPORATION (JP) 2011-03-24 US disclosed
EP-2009070-B1 Ink-jet ink and method of producing the same, color filter and method of producing the same, display device, and method of forming functional film FUJIFILM CORP (JP) 2010-11-24 EP disclosed
US-20090035535-A1 INK-JET INK AND METHOD OF PRODUCING THE SAME, COLOR FILTER AND METHOD OF PRODUCING THE SAME, DISPLAY DEVICE, AND METHOD OF FORMING FUNCTIONAL FILM FUJIFILM CORPORATION (JP) 2009-02-05 US disclosed
EP-2009070-A1 Ink-jet ink and method of producing the same, color filter and method of producing the same, display device, and method of forming functional film FUJIFILM Corporation (JP) 2008-12-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110070407-A1 NEAR-INFRARED ABSORPTIVE DYE-CONTAINING CURABLE COMPOSITION, INK COMPOSITION AND METHOD OF PRODUCING NEAR-INFRARED ABSORPTIVE FILTER RB1, IK, STRA6 HSD17B10 2990/4885ALDH1A1 159/4885TSHR 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.